Evaluation of HIV-1 reservoir size and broadly neutralizing antibody susceptibility in acute antiretroviral therapy-treated individuals-Reference-Cited by-同舟云学术

Evaluation of HIV-1 reservoir size and broadly neutralizing antibody susceptibility in acute antiretroviral therapy-treated individuals

Published:2021-09-29 Issue:2 Volume:36 Page:205-214
ISSN:0269-9370
Container-title:AIDS
language:en
Short-container-title:

Author:

Moldt Brian,Günthard Huldrych F.,Workowski Kimberly A.,Little Susan J.,Eron Joseph J.,Overton Edgar T.,Lehmann Clara,Rokx Casper,Kozal Michael J.,Gandhi Rajesh T.,Braun Dominique L.,Parvangada Aiyappa,Li Jiani,Martin Ross,Selzer Lisa,Cox Stephanie,Margot Nicolas,Liu Hui,Slamowitz Debbie,Makadzange Tariro,Collins Sean E.,Geleziunas Romas,Callebaut Christian

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Infectious Diseases,Immunology,Immunology and Allergy

Reference42 articles.

1. Re-emergence of HIV after stopping therapy;Chun;Nature,1999

2. Rapid HIV RNA rebound after antiretroviral treatment interruption in persons durably suppressed in Fiebig I acute HIV infection;Colby;Nat Med,2018

3. Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy;Finzi;Nat Med,1999

4. Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy;Finzi;Science,1997

5. Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells;Siliciano;Nat Med,2003

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Making a Monkey out of Human Immunodeficiency Virus/Simian Immunodeficiency Virus Pathogenesis: Immune Cell Depletion Experiments as a Tool to Understand the Immune Correlates of Protection and Pathogenicity in HIV Infection;Viruses;2024-06-17

2. Prevalence of resistance-associated viral variants to the HIV-specific broadly neutralising antibody 10-1074 in a UK bNAb-naïve population;Frontiers in Immunology;2024-03-18

3. Development of a highly sensitive and specific intact proviral DNA assay for HIV-1 subtype B and C;Virology Journal;2024-01-31

4. Neutralizing the threat: harnessing broadly neutralizing antibodies against HIV-1 for treatment and prevention;MICROB CELL;2024

5. Broadly neutralizing antibodies targeting HIV: Progress and challenges;Clinical Immunology;2023-12